These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 20149605

  • 1. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA, Liu D, Zhou QY, Huang SF, Luo P, Xiang Y, Sun S, Luo D, Dong YF, Zhang LP.
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [Abstract] [Full Text] [Related]

  • 2. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
    Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ.
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
    [Abstract] [Full Text] [Related]

  • 3. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
    Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW, McKim SE, Parsons C, Rippe RA, Wheeler MD.
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
    [Abstract] [Full Text] [Related]

  • 4. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z, Mizuno S, Nakamura T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [Abstract] [Full Text] [Related]

  • 5. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL.
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [Abstract] [Full Text] [Related]

  • 6. Biliary intervention augments chemotactic reaction and aggravates cholestatic liver injury in rats.
    Chuang JH, Chang NK, Huang CC, Lo SK, Wang HC, Chen CM, Wu CL, Chou MH, Lin TK.
    J Surg Res; 2004 Aug; 120(2):210-8. PubMed ID: 15234215
    [Abstract] [Full Text] [Related]

  • 7. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N, Hatano E, Taura K, Tada M, Kodama Y, Nitta T, Iwaisako K, Seo S, Nakajima A, Ikai I, Uemoto S.
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [Abstract] [Full Text] [Related]

  • 8. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H, Bronk SF, Taniai M, Canbay A, Gores GJ.
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH, Rickenbacher A, Humar B, Weber A, Raptis DA, Lehmann K, Stieger B, Moritz W, Soll C, Georgiev P, Fischer D, Laczko E, Graf R, Clavien PA.
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
    Tuchweber B, Desmoulière A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G.
    Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
    [Abstract] [Full Text] [Related]

  • 20. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver.
    Kwak BJ, Choi HJ, Kim OH, Kim KH, You YK, Lee TY, Ahn J, Kim SJ.
    J Surg Res; 2019 Sep; 241():254-263. PubMed ID: 31035140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.